Johnson & Johnson clears a few hurdles, but Wall Street focuses on weak guidance
Johnson & Johnson’s stock dropped more than 3% Wednesday after the medical-technology and drug company beat estimates for the ...
Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth
The pharmaceutical company’s latest earnings exceeded Wall Street’s expectations as it braces for one of its top-selling ...
J&J Tops Quarterly Profit Estimates on Cancer Drug Sales
Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in ...
Balanced Expectations Amid Challenges and Opportunities for Johnson & Johnson: Hold Rating Issued
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee ...
Wall Street Lunch: AI Project Stargate A Go
Project Stargate will see companies like Oracle, SoftBank, MGX, and OpenAI commit an initial $100 billion to build data ...
Wall Street's Greatest Dividend Stock -- a Small-Cap Company 99% of Investors Have Never Heard of -- Is the Cheapest It's Been in Over a Decade
What Hartford Funds and Ned Davis Research found was that income stocks more than doubled the average annual return of ...
Biden insisted he didn’t sign executive order just weeks after doing so, Speaker Johnson reveals
House Speaker Mike Johnson revealed President Biden insisted to him he hadn’t issued an executive order freezing liquid ...
Oil, tech stocks push and pull on Wall Street; Johnson & Johnson buys drugmaker for $14B
NEW YORK — Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said ...
Forbes26d
Will Mike Johnson Get Reelected As Speaker? Johnson Faces Right-Wing Pushback—Despite Trump And Musk’s Endorsements
(Tom Williams/CQ-Roll Call, Inc via Getty Images) Trump endorsed Johnson Monday and told partygoers at Mar-a-Lago on New Year’s Eve, “he’s the one that can win right now,” the Wall Street ...